The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005 This international ...
At AACR the Company will present the results of its verification study evaluating a compact proprietary combination of blood-derived mRNA biomarkers and an AI-assisted modeling approach designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results